CD44 and breast cancer: Also, CD NPs demonstrated the highest anti-CSC and proapoptotic activities in mammary tumor, as evidenced by the minimum percentage of CD44+-stained cells (20.26 ± 2.19%) and the maximum percentage of caspase 3+-stained cells (95.71 ± 1.49%) compared to ZD NPs and Fu.